相似文献
1
Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment.选择性 5-羟色胺再摄取抑制剂抗抑郁药与华法林维持治疗期间过度抗凝的风险。
Br J Clin Pharmacol. 2011 Nov;72(5):798-805. doi: 10.1111/j.1365-2125.2011.04004.x.
2
Proton pump inhibitors and the risk of overanticoagulation during acenocoumarol maintenance treatment.质子泵抑制剂与华法林维持治疗期间过度抗凝的风险。
Br J Haematol. 2011 May;153(3):379-85. doi: 10.1111/j.1365-2141.2011.08633.x. Epub 2011 Mar 21.
3
Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulants.抗菌药物与醋硝香豆素或苯丙香豆素抗凝剂联合使用相关的抗凝过度。
Thromb Haemost. 2002 Nov;88(5):705-10.
4
Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs.
Clin Pharmacol Ther. 2001 Jun;69(6):451-7. doi: 10.1067/mcp.2001.115723.
5
Overanticoagulation associated with combined use of antifungal agents and coumarin anticoagulants.
Clin Pharmacol Ther. 2002 Jun;71(6):496-502. doi: 10.1067/mcp.2002.124470.
6
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.文拉法辛：体外对细胞色素P450 2D6依赖性丙咪嗪和地昔帕明代谢的抑制作用；与选定的选择性5-羟色胺再摄取抑制剂的比较研究，以及对人肝细胞色素P450 3A4、细胞色素P450 2C9和细胞色素P450 1A2的影响。
Br J Clin Pharmacol. 1997 Jun;43(6):619-26. doi: 10.1046/j.1365-2125.1997.00591.x.
7
Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug-drug interactions during acenocoumarol treatment.CYP2C9 多态性对香豆素类药物华法林相互作用易感性的影响。
Pharmacogenomics. 2013 May;14(7):745-53. doi: 10.2217/pgs.13.55.
8
In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.体外研究 5-羟色胺和去甲肾上腺素再摄取抑制剂对人血小板黏附和凝血的影响。
Pharmacol Rep. 2012;64(4):979-83. doi: 10.1016/s1734-1140(12)70894-0.
9
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.通过抑制5-羟色胺再摄取诱导暴露于新环境中的小鼠产生运动亢进。各类抗抑郁药的药理学特征。
Pharmacol Biochem Behav. 2002 Apr;71(4):667-80. doi: 10.1016/s0091-3057(01)00701-8.
10
Implication of 5-HT2 receptor subtypes in the mechanism of action of antidepressants in the four plates test.5-羟色胺2受体亚型在四板试验中抗抑郁药作用机制中的意义
Psychopharmacology (Berl). 2005 May;179(2):418-29. doi: 10.1007/s00213-004-2044-y. Epub 2004 Nov 18.
引用本文的文献
1
Effects of the 5-Hydroxytryptamine 3 Receptor Antagonist Palonosetron on Hemostasis: An In Vitro Study Using Thromboelastography.5-羟色胺3受体拮抗剂帕洛诺司琼对止血的影响：一项使用血栓弹力图的体外研究
Medicina (Kaunas). 2025 Apr 8;61(4):682. doi: 10.3390/medicina61040682.
2
Selective Serotonin Reuptake Inhibitor Use and Risk of Major Bleeding during Treatment with Vitamin K Antagonists: Results of A Cohort Study.选择性 5-羟色胺再摄取抑制剂的使用与维生素 K 拮抗剂治疗期间大出血风险的相关性：一项队列研究的结果。
Thromb Haemost. 2023 Feb;123(2):245-254. doi: 10.1055/a-1957-6305. Epub 2022 Oct 8.
3
Emotional Blunting, Cognitive Impairment, Bone Fractures, and Bleeding as Possible Side Effects of Long-Term Use of SSRIs.长期使用选择性5-羟色胺再摄取抑制剂可能产生的副作用：情感迟钝、认知障碍、骨折和出血
Clin Neuropsychiatry. 2019 Apr;16(2):75-85.
4
Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.新冠病毒治疗药物的印度人群基因组药物基因组学全景。
Pharmacogenomics. 2021 Jul;22(10):603-618. doi: 10.2217/pgs-2021-0028. Epub 2021 Jun 18.
5
Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial.选择性 5-羟色胺再摄取抑制剂与抗凝心房颤动患者出血风险：来自 ROCKET AF 试验的分析。
J Am Heart Assoc. 2018 Aug 7;7(15):e008755. doi: 10.1161/JAHA.118.008755.
6
Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.选择性 5-羟色胺再摄取抑制剂对服用华法林的房颤患者出血风险的影响。
Am J Cardiol. 2014 Aug 15;114(4):583-6. doi: 10.1016/j.amjcard.2014.05.037. Epub 2014 Jun 5.
7
The Rotterdam Study: 2014 objectives and design update.《鹿特丹研究：2014 年目标与设计更新》
Eur J Epidemiol. 2013 Nov;28(11):889-926. doi: 10.1007/s10654-013-9866-z. Epub 2013 Nov 21.
本文引用的文献
1
Proton pump inhibitors and the risk of overanticoagulation during acenocoumarol maintenance treatment.质子泵抑制剂与华法林维持治疗期间过度抗凝的风险。
Br J Haematol. 2011 May;153(3):379-85. doi: 10.1111/j.1365-2141.2011.08633.x. Epub 2011 Mar 21.
2
Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies.分析个体用药作为前瞻性基于人群队列研究中暴露的时变决定因素。
Eur J Epidemiol. 2010 Apr;25(4):245-51. doi: 10.1007/s10654-010-9451-7. Epub 2010 Apr 1.
3
Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function.全基因组关联研究的荟萃分析确定了多个与肺功能相关的基因座。
Nat Genet. 2010 Jan;42(1):45-52. doi: 10.1038/ng.500. Epub 2009 Dec 13.
4
The Rotterdam Study: 2010 objectives and design update.鹿特丹研究：2010年目标与设计更新
Eur J Epidemiol. 2009;24(9):553-72. doi: 10.1007/s10654-009-9386-z.
5
A genome-wide association study of acenocoumarol maintenance dosage.醋硝香豆素维持剂量的全基因组关联研究。
Hum Mol Genet. 2009 Oct 1;18(19):3758-68. doi: 10.1093/hmg/ddp309. Epub 2009 Jul 4.
6
Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands.荷兰可预防的药物相关住院情况的发生率及风险因素
Arch Intern Med. 2008 Sep 22;168(17):1890-6. doi: 10.1001/archinternmed.2008.3.
7
Dependency of phenprocoumon dosage on polymorphisms in the VKORC1 and CYP2C9 genes.苯丙香豆素剂量对维生素K环氧化物还原酶复合体亚单位1（VKORC1）和细胞色素P450 2C9（CYP2C9）基因多态性的依赖性。
J Thromb Thrombolysis. 2009 Aug;28(2):211-4. doi: 10.1007/s11239-008-0252-8. Epub 2008 Jul 16.
8
Gastro-intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look.选择性5-羟色胺再摄取抑制剂治疗的胃肠道出血风险：新视角
Br J Clin Pharmacol. 2008 Jul;66(1):76-81. doi: 10.1111/j.1365-2125.2008.03154.x. Epub 2008 May 6.
9
Adverse drug reaction-related hospitalisations: a population-based cohort study.药物不良反应相关住院情况：一项基于人群的队列研究。
Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):365-71. doi: 10.1002/pds.1565.
10
Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin.对华法林进行CYP2C9和VKORC1等位基因的药物遗传学检测。
Genet Med. 2008 Feb;10(2):139-50. doi: 10.1097/GIM.0b013e318163c35f.
Zotero 插件